186 related articles for article (PubMed ID: 37877158)
1. Transcriptional background effects on a tumor driver gene in different pigment cell types of medaka.
Abdulsahib S; Boswell W; Boswell M; Savage M; Schartl M; Lu Y
J Exp Zool B Mol Dev Evol; 2024 May; 342(3):252-259. PubMed ID: 37877158
[TBL] [Abstract][Full Text] [Related]
2. A mutated EGFR is sufficient to induce malignant melanoma with genetic background-dependent histopathologies.
Schartl M; Wilde B; Laisney JA; Taniguchi Y; Takeda S; Meierjohann S
J Invest Dermatol; 2010 Jan; 130(1):249-58. PubMed ID: 19609310
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional control analyses of the Xiphophorus melanoma oncogene.
Regneri J; Volff JN; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2015 Dec; 178():116-127. PubMed ID: 26348392
[TBL] [Abstract][Full Text] [Related]
4. Genetic, biochemical and evolutionary facets of Xmrk-induced melanoma formation in the fish Xiphophorus.
Meierjohann S; Schartl M; Volff JN
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Jul; 138(3):281-9. PubMed ID: 15533786
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
Mishra RR; Kneitz S; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2014 Jun; 163():64-76. PubMed ID: 24462553
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction by the oncogenic receptor tyrosine kinase Xmrk in melanoma formation of Xiphophorus.
Wellbrock C; Gómez A; Schartl M
Pigment Cell Res; 1997; 10(1-2):34-40. PubMed ID: 9170160
[TBL] [Abstract][Full Text] [Related]
7. Expression regulation triggers oncogenicity of xmrk alleles in the Xiphophorus melanoma system.
Regneri J; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jan; 155(1):71-80. PubMed ID: 21527356
[TBL] [Abstract][Full Text] [Related]
8. Expression signatures of early-stage and advanced medaka melanomas.
Klotz B; Kneitz S; Regensburger M; Hahn L; Dannemann M; Kelso J; Nickel B; Lu Y; Boswell W; Postlethwait J; Warren W; Kunz M; Walter RB; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2018 Jun; 208():20-28. PubMed ID: 29162497
[TBL] [Abstract][Full Text] [Related]
9. The macromelanophore locus and the melanoma oncogene Xmrk are separate genetic entities in the genome of Xiphophorus.
Weis S; Schartl M
Genetics; 1998 Aug; 149(4):1909-20. PubMed ID: 9691046
[TBL] [Abstract][Full Text] [Related]
10. Signalling by the oncogenic receptor tyrosine kinase Xmrk leads to activation of STAT5 in Xiphophorus melanoma.
Wellbrock C; Geissinger E; Gómez A; Fischer P; Friedrich K; Schartl M
Oncogene; 1998 Jun; 16(23):3047-56. PubMed ID: 9662338
[TBL] [Abstract][Full Text] [Related]
11. Application of the Transcriptional Disease Signature (TDSs) to Screen Melanoma-Effective Compounds in a Small Fish Model.
Lu Y; Boswell W; Boswell M; Klotz B; Kneitz S; Regneri J; Savage M; Mendoza C; Postlethwait J; Warren WC; Schartl M; Walter RB
Sci Rep; 2019 Jan; 9(1):530. PubMed ID: 30679619
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Xiphophorus and human melanoma transcriptomes reveals conserved pathway interactions.
Lu Y; Boswell M; Boswell W; Kneitz S; Hausmann M; Klotz B; Regneri J; Savage M; Amores A; Postlethwait J; Warren W; Schartl M; Walter R
Pigment Cell Melanoma Res; 2018 Jul; 31(4):496-508. PubMed ID: 29316274
[TBL] [Abstract][Full Text] [Related]
13. Evolutionary origin and molecular biology of the melanoma-inducing oncogene of Xiphophorus.
Schartl A; Dimitrijevic N; Schartl M
Pigment Cell Res; 1994 Dec; 7(6):428-32. PubMed ID: 7761351
[TBL] [Abstract][Full Text] [Related]
14. Melanoma loss-of-function mutants in Xiphophorus caused by Xmrk-oncogene deletion and gene disruption by a transposable element.
Schartl M; Hornung U; Gutbrod H; Volff JN; Wittbrodt J
Genetics; 1999 Nov; 153(3):1385-94. PubMed ID: 10545466
[TBL] [Abstract][Full Text] [Related]
15. MITF-M plays an essential role in transcriptional activation and signal transduction in Xiphophorus melanoma.
Delfgaauw J; Duschl J; Wellbrock C; Froschauer C; Schartl M; Altschmied J
Gene; 2003 Nov; 320():117-26. PubMed ID: 14597395
[TBL] [Abstract][Full Text] [Related]
16. Activation of transcription of the melanoma inducing Xmrk oncogene by a GC box element.
Baudler M; Duschl J; Winkler C; Schartl M; Altschmied J
J Biol Chem; 1997 Jan; 272(1):131-7. PubMed ID: 8995238
[TBL] [Abstract][Full Text] [Related]
17. PI3-kinase is involved in mitogenic signaling by the oncogenic receptor tyrosine kinase Xiphophorus melanoma receptor kinase in fish melanoma.
Wellbrock C; Fischer P; Schartl M
Exp Cell Res; 1999 Sep; 251(2):340-9. PubMed ID: 10471319
[TBL] [Abstract][Full Text] [Related]
18. Xmrk in medaka: a new genetic melanoma model.
Patton EE; Nairn RS
J Invest Dermatol; 2010 Jan; 130(1):14-7. PubMed ID: 20010863
[TBL] [Abstract][Full Text] [Related]
19. Histopathologic features of melanocytic tumors in
Sugiyama A; Schartl M; Naruse K
J Toxicol Pathol; 2019 Apr; 32(2):111-117. PubMed ID: 31092978
[TBL] [Abstract][Full Text] [Related]
20. Activation of the Xmrk proto-oncogene of Xiphophorus by overexpression and mutational alterations.
Dimitrijevic N; Winkler C; Wellbrock C; Gómez A; Duschl J; Altschmied J; Schartl M
Oncogene; 1998 Apr; 16(13):1681-90. PubMed ID: 9582016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]